Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05584657 · ClinicalTrials.gov registry record · Phase 3
Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
A Phase 3 study of Urinary Tract Infections and Cystitis, sponsored by Iterum Therapeutics, International Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,229
- Enrollment target
- 20
- Study locations
NCT05584657: Completed Phase 3 study of Urinary Tract Infections and Cystitis, sponsored by Iterum Therapeutics, International Limited.
NCT05584657 is a Phase 3 study of Urinary Tract Infections and Cystitis that has completed, run by Iterum Therapeutics, International Limited. The registered enrollment target is 2,229 participants, above the 393-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (467% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05584657, a Phase 3 study of Urinary Tract Infections and Cystitis, has completed, sponsored by Iterum Therapeutics, International Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,229 participants
- Enrollment target
- 20
- Study locations
Study Summary
Study 310 is a clinical study which compares the effectiveness of oral sulopenem versus oral amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection.
Primary Outcome
Clinical Success (resolution of uncomplicated urinary tract infection (uUTI) symptoms present at study entry and no new symptoms) AND Microbiologic success (eradication of the baseline pathogen)
Conditions Studied
Interventions
- DRUG Amoxicillin/clavulanate
- DRUG Sulopenem etzadroxil/probenecid
Study Locations (20)
California
- Medical Facility - Bakersfield
- Medical Facility - Chula Vista
- Medical Facility - Fullerton
- Medical Facility - Garden Grove
- Medical Facility - Huntington Beach
- Medical Facility 2 - Huntington Park
- Medical Facility - Huntington Park
- Medical Facility - Irvine
- Medical Facility - La Mesa
- Medical Facility - Lancaster
Arizona
- Medical Facility - Peoria
- Medical Facility3 - Phoenix
- Medical Facility - Phoenix
- Medical Facility2 - Phoenix
- Medical Facility - Tucson
Alabama
- Medical Facility - Cullman
- Medical Facility - Saraland
- Medical Facility - Sheffield
Arkansas
- Medical Facility2 - Hot Springs
- Medical Facility - Hot Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,229 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2023-11-21 |
| Phase | Phase 3 |
What the finished NCT05584657 record still lists
NCT05584657 is an interventional study that assigns participants to a tested intervention. Its 2,229 participants enrollment target places it among the larger protocols in the corpus, above the 393-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (467% higher).
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Amoxicillin/clavulanate is the first listed.
NCT05584657 names 20 study sites across 4 states, led by California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT05584657 about?
NCT05584657 is a clinical study titled "Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women". Study 310 is a clinical study which compares the effectiveness of oral sulopenem versus oral amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection.
What is the current status of trial NCT05584657?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,229 participants. The study started on 2022-10-18. Estimated completion is 2023-11-21.
What conditions does trial NCT05584657 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Cystitis.
What interventions are being tested in trial NCT05584657?
The interventions under investigation include: Amoxicillin/clavulanate (DRUG), Sulopenem etzadroxil/probenecid (DRUG).
Who is sponsoring clinical trial NCT05584657?
This trial is sponsored by Iterum Therapeutics, International Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05584657 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05584657's enrollment target sits among peer trials
2,229 3rd of 34 higher than 32 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)
COMPLETED · Phase 3
-
Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections
COMPLETED · Phase 3
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI